WHO Model Prescribing Information: Drugs Used in Anaesthesia
(1989; 60 pages) [French] View the PDF document
Table of Contents
View the documentPreface
View the documentIntroduction
Open this folder and view contentsPremedication
Open this folder and view contentsGeneral anaesthetics and oxygen
Close this folderLocal anaesthetics
View the documentBupivacaine
View the documentLidocaine
View the documentTetracaine
View the documentEpinephrine (for use with local anaesthetics)
Open this folder and view contentsNon-opioid analgesics
Open this folder and view contentsOpioid analgesics and antagonists
Open this folder and view contentsMuscle relaxants and cholinesterase inhibitors
Open this folder and view contentsBlood substitutes
Open this folder and view contentsSolutions for correcting water and electrolyte imbalance
Open this folder and view contentsAntacid for use in obstetric practice
View the documentAnaesthesia at the District Hospital
View the documentSelected WHO publications of related interest
View the documentBack cover
 

Tetracaine

Group: local anaesthetic agent
Solution (eye drops): 5 mg (hydrochloride)/ml (0.5%)

General information

Tetracaine is a local anaesthetic that penetrates the cornea and conjunctiva. It is effective after topical application to the eye within 30 seconds and anaesthesia persists for at least 15 minutes.

Clinical information

Uses

Short-lasting local anaesthesia of the cornea and conjunctiva.

Dosage and administration

One or 2 drops of 0.5% solution should be instilled into the conjunctival sac.

Contraindications

• Known hypersensitivity to tetracaine.
• Ocular inflammation or infection.

Precautions

The anaesthetized eye should be protected from dust and bacteriological contamination until sensation is fully restored.

Prolonged use has resulted in corneal opacities.

Adverse effects

A localized burning sensation may occur and, more rarely, lacrimation and photophobia.

Storage

Tetracaine eye drops should be kept in well-closed containers protected from light, and should not be allowed to freeze.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018